Estrella Tortosa-Gomez

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 41 publications

Eligibility for lecanemab therapy in a biomarker defined memory clinic cohort: A five-year analysis.

Eligibility for lecanemab therapy in a biomarker defined memory clinic cohort: A five-year analysis.

Journal: Journal of Alzheimer's disease : JAD

Published: July 08, 2026

MAPT p.V363I mutation in a patient with presenile dementia and late amyotrophic lateral sclerosis.

MAPT p.V363I mutation in a patient with presenile dementia and late amyotrophic lateral sclerosis.

Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration

Published: December 27, 2025

Clinical phenotype of frontotemporal dementia associated with the Pro392Leu SQSTM1 mutation.

Clinical phenotype of frontotemporal dementia associated with the Pro392Leu SQSTM1 mutation.

Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration

Published: August 23, 2025

Plasma Biomarkers in the Distinction of Alzheimer's Disease and Frontotemporal Dementia.

Plasma Biomarkers in the Distinction of Alzheimer's Disease and Frontotemporal Dementia.

Journal: International journal of molecular sciences

Published: December 20, 2024

Plasma Neurodegenerative Biomarkers in Cognitively Preserved Nonagenarians.

Plasma Neurodegenerative Biomarkers in Cognitively Preserved Nonagenarians.

Journal: Aging and disease

Published: October 01, 2024

ADAM10 and its role in Alzheimer disease.

ADAM10 and its role in Alzheimer disease.

Journal: Neurologia

Published: June 21, 2024

A systematic review of progranulin concentrations in biofluids in over 7,000 people-assessing the pathogenicity of GRN mutations and other influencing factors.

A systematic review of progranulin concentrations in biofluids in over 7,000 people-assessing the pathogenicity of GRN mutations and other influencing factors.

Journal: Alzheimer's research & therapy

Published: October 27, 2023

ADAM10 Gene Variants in AD Patients and Their Relationship to CSF Protein Levels.

ADAM10 Gene Variants in AD Patients and Their Relationship to CSF Protein Levels.

Journal: International journal of molecular sciences

Published: February 14, 2023

TRIM25 mutation (p.C168*), coding for an E3 ubiquitin ligase, is a cause of early-onset autosomal dominant dementia with amyloid load and parkinsonism.

TRIM25 mutation (p.C168*), coding for an E3 ubiquitin ligase, is a cause of early-onset autosomal dominant dementia with amyloid load and parkinsonism.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: July 08, 2022

Heterozygous and Homozygous Variants in SORL1 Gene in Alzheimer's Disease Patients: Clinical, Neuroimaging and Neuropathological Findings.

Heterozygous and Homozygous Variants in SORL1 Gene in Alzheimer's Disease Patients: Clinical, Neuroimaging and Neuropathological Findings.

Journal: International journal of molecular sciences

Published: March 15, 2022

Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum.

Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum.

Journal: JAMA neurology

Published: January 31, 2022

De Novo PS1 Mutation (Pro436Gln) in a Very Early-Onset Posterior Variant of Alzheimer's Disease Associated with Spasticity: A Case Report.

De Novo PS1 Mutation (Pro436Gln) in a Very Early-Onset Posterior Variant of Alzheimer's Disease Associated with Spasticity: A Case Report.

Journal: Journal of Alzheimer's disease : JAD

Published: August 09, 2021

Showing 1-12 of 41

Last Updated: 09/26/2026